Malta - English - Medicines Authority

morningside healthcare limited - ethambutol hydrochloride - film-coated tablet - ethambutol hydrochloride 100 mg - antimycobacterials

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - ethambutol hydrochloride, quantity: 400 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; gelatin; calcium hydrogen phosphate dihydrate; maize starch; ethylcellulose; sorbitol; titanium dioxide; macrogol 6000 - indications as at 04 jan 2002 : oral administation : myambutol is indicated for the treatment of pulmonary tuberculosis, as shown by a large number of studies by investigators throughout the world. it has also been used successfully in cases of primary tuberculosis and extrapulmonary forms of tuberculosis, including miliary tuberculosis, tuberculois meningitis, tuberculosis of bones and joints, genitourinary tuberculosis, tuberculous of the shin and tuberculous eye diseases. it should not be used as the sole antituberculosis drug, but should be used in conjuction with at least one other antituberculosis drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculosis therapy, i.e. initial treatment, the most frequently used regimens have included three of the following drugs - myambutol, isoniazid, rifampicin and streptomycin - for the first 2-4 months for example, myambutol plus isoniazid plus rifampicin or myambutol plus isoniazid plus streptomycin then continuing with a two drug regimen such as myambutol plus isoniazid or myambutol plus rifampicin. in patients who have received previous antituberculosis therapy, mycobacterial resistance to other durgs used in initial therapy is frequent. consequently, in such retreatment cases myambutol should be combined with at least one of the second-line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. antituberculosis drugs used with myambutol have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. isoniazid, aminosalicylic acid, and streptomycin have also been use in multiple drug regimens. alternating drug regimens have also been utilised.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

macleods pharmaceuticals ltd. - ethambutol (ethambutol hydrochloride) - tablets film-coated - 400mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

macleods pharmaceuticals ltd. - ethambutol (ethambutol hydrochloride) - tablets film-coated - 100mg

Malta - English - Medicines Authority

peckforton pharmaceuticals ltd - ethambutol hydrochloride - tablet - ethambutol hydrochloride 400 milligram(s) - antimycobacterials

Malta - English - Medicines Authority

central procurement & supplies unit - ethambutol hydrochloride - film-coated tablet - ethambutol hydrochloride 100 mg - antimycobacterials

United States - English - NLM (National Library of Medicine)

a-s medication solutions - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride tablets, usp are indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: ethambutol hydrochloride, usp plus isoniazid ethambutol hydrochloride, usp plus isoniazid plus streptomycin in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol hydrochloride should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been

Malta - English - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - ethambutol hydrochloride - tablet - ethambutol hydrochloride 400 mg - antimycobacterials

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - ethambutol hydrochloride - film-coated tablet - ethambutol hydrochloride 400 mg - antimycobacterials

Malta - English - Medicines Authority

intrapharm laboratories limited the courtyard barns, choke lane, cookham dean, maidenhead, berks, sl6 6pt, united kingdom - ethambutol hydrochloride - film-coated tablet - ethambutol hydrochloride 400 mg - antimycobacterials